74 reports

Bipolar Disorder (Manic Depression) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2019 ##.

  • Bipolar Disorder
  • Depression
  • Mental Health
  • Demand
  • Product Initiative

Global Unipolar Depression Epidemiology and Patient Flow Analysis - 2017 ##.

  • Depression
  • Mental Health
  • United States
  • World
  • Forecast

Global Major Depression Epidemiology and Patient Flow Analysis - 2017 ##.

  • Depression
  • Mental Health
  • United States
  • World
  • Forecast

Global Bipolar Depression Epidemiology and Patient Flow Analysis - 2017 ##.

  • Depression
  • Mental Health
  • United States
  • World
  • Forecast

Europe Unipolar Depression Epidemiology and Patient Flow Analysis - 2017 ##.

  • Depression
  • Europe
  • France
  • Germany
  • Forecast

Europe Major Depression Epidemiology and Patient Flow Analysis - 2017 ##.

  • Depression
  • Europe
  • France
  • Germany
  • Forecast

Europe Bipolar Depression Epidemiology and Patient Flow Analysis - 2017 ##.

  • Depression
  • Europe
  • France
  • Germany
  • Forecast
  • related to depression and other mental disorders.
  • According to WHO, depression is the leading cause of disability in

Lilly' s first multibillion-dollar drug, Prozac is one of the first therapies in its class SSRI to treat clinical depression by blocking the uptake of serotonin within the human brain.

  • Depression
  • World
  • Market Size
  • Novartis AG
  • Pfizer Inc.

Global Depression Epidemiology and Patient Flow Analysis - 2016 ##.

  • Depression
  • Mental Health
  • United States
  • World
  • Forecast
  • Depression
  • Strattera is indicated for the treatment of Attention-Deficit/Hyperactivity Disorder. It is also used to treat depression problems.

Johnson & Johnson is seeking to gain competitive advantage by developing nasal spray for treatment-resistant depression (which is one of the major unmet medical needs).

  • Depression
  • Allergan plc
  • Eli Lilly & Co.
  • Pfizer Inc.
  • Takeda Pharmaceutical Company Limited
  • TYPES OF DEPRESSION
  • CAUSES & SYMPTOMS OF DEPRESSION

Various other reasons that can trigger depression are trauma, loss of loved ones, a difficult relationship, or any stressful situation.

  • Depression
  • World
  • AstraZeneca PLC
  • Lundbeck Inc.
  • Pfizer Inc.
  • MHDS - MARKET SIZE AND FORECAST 2017-2022
  • ADVANCES IN TECHNOLOGY IN TREATING MENTAL DISORDERS

AD is one of the most common types of NDDs.

  • Depression
  • Eli Lilly & Co.
  • F. Hoffmann-La Roche Ltd.
  • Johnson & Johnson
  • Merck & Co., Inc.

Physician Views: Can Lundbeck and Otsuka' s newly approved Rexulti compete with branded and generic competition in the schizophrenia and depression markets?

  • Depression
  • Mental Health
  • Pathology
  • Psychotic Disorder
  • United States

Global Depressive Disorder Market DataPack (2016-2020) Types of Depression Causes & Symptoms of Depression Global Depressive Disorder Market by Value (2010-2015) Global Depressive Disorder Market Forecast by Value (2016-2020) Global Depressive Disorder Market by Region (2015) G

  • Depression
  • Mental Health
  • Pathology
  • World
  • Forecast
  • Depression
  • GLOBAL DEPRESSION SCREENING MARKET FOR DEPRESSION SCREENING TESTS, BY REGION,

Depression affects an estimated one in ## adults (##. ##%) per year and one in six people (##. ##%) will experience depression at some time in their life.

  • Depression
  • North America
  • United States
  • World
  • Demand

It is a very common condition that affects ## in every ## Americans.

  • Antidepressant
  • Depression
  • Mental Health
  • Therapy
  • Market Size
  • Clinical Trial profile. 45 Trial Title
  • Target

CLINICAL TRIALS BY END POINT STATUS POST PARTUM DEPRESSION (MATERNAL DEPRESSION / POSTNATAL DEPRESSION) THERAPEUTICS CLINICAL TRIALS, GLOBAL, BY END POINT POST PARTUM DEPRESSION (MATERNAL DEPRESSION / POSTNATAL DEPRESSION) THERAPEUTICS

  • Depression
  • Therapy
  • World
  • Product Initiative
  • SAGE Therapeutics
  • TOP COMPANIES PARTICIPATING IN BIPOLAR DISORDER (MANIC DEPRESSION) THERAPEUTICS CLINICAL TRIALS
  • IRAN HAS THE HIGHEST NUMBER OF BIPOLAR DISORDER (MANIC DEPRESSION) CLINICAL TRIALS, AS OF NOVEMBER 2018.

BIPOLAR DISORDER (MANIC DEPRESSION) THERAPEUTICS CLINICAL TRIALS, GLOBAL, TOP COMPANIES BY PHASE, 2018* BIPOLAR DISORDER (MANIC DEPRESSION) THERAPEUTICS CLINICAL TRIALS, GLOBAL, TOP COMPANIES BY PHASE, 2018* BIPOLAR DISORDER (MANIC DEPRESSION) THERAPEUTICS CLINICAL TRIALS,

  • Bipolar Disorder
  • Clinical Trial
  • Depression
  • Neurology
  • World
  • LATEST CLINICAL TRIALS NEWS ON TREATMENT RESISTANT DEPRESSION
  • TREATMENT RESISTANT DEPRESSION THERAPEUTICS CLINICAL TRIALS, GLOBAL, ONGOING CLINICAL TRIALS BY PROMINENT DRUGS, 2018*

TREATMENT RESISTANT DEPRESSION THERAPEUTICS, E## COUNTRIES, CLINICAL TRIALS BY PHASE, 2018* CLINICAL TRIALS BY PHASE IN E## COUNTRIES TREATMENT RESISTANT DEPRESSION THERAPEUTICS, E## COUNTRIES, CLINICAL TRIALS BY PHASE, 2018* TREATMENT RESISTANT DEPRESSION THERAPEUTICS, E## CO

  • Clinical Trial
  • Depression
  • Therapy
  • World
  • Product Initiative
  • RESPIRATORY DEPRESSION (HYPOVENTILATION) THERAPEUTICS CLINICAL TRIALS, GLOBAL, ONGOING CLINICAL TRIALS BY PROMINENT DRUGS,
  • Target

RESPIRATORY DEPRESSION (HYPOVENTILATION) THERAPEUTICS CLINICAL TRIALS, GLOBAL, TOP COMPANIES BY PHASE, 2018* RESPIRATORY DEPRESSION (HYPOVENTILATION) THERAPEUTICS CLINICAL TRIALS, GLOBAL, TOP COMPANIES BY PHASE, 2018* RESPIRATORY DEPRESSION (HYPOVENTILATION) THERAPEUTICS C

  • Depression
  • Therapy
  • World
  • Product Initiative
  • RespireRx Pharmaceuticals Inc.
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

PSYCHOTIC MAJOR DEPRESSION THERAPEUTICS CLINICAL TRIALS, GLOBAL, TOP COMPANIES BY PHASE, 2018* PSYCHOTIC MAJOR DEPRESSION THERAPEUTICS CLINICAL TRIALS, GLOBAL, TOP COMPANIES BY PHASE, 2018* PSYCHOTIC MAJOR DEPRESSION THERAPEUTICS CLINICAL TRIALS, GLOBAL, TOP COMPANIES BY P

  • Depression
  • Hormone
  • Hospital
  • World
  • Product Initiative
  • SUBTYPES OF MAJOR DEPRESSIVE DISORDER
  • PRESENTS THE DISEASE MANAGEMENT MODEL FOR MDD.

COND=DEPRESSION& INTR=VORTIOXETINE& PH ASE=##& RANK=##.

  • Depression
  • Alkermes plc
  • Allergan plc
  • Lundbeck Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • 3.6.1 Epidemiological Forecast Insight

PEOPLE WHO SUFFER FROM BED STRUGGLE WITH FEELINGS OF DISGUST AND GUILT, AND FREQUENTLY SUFFER FROM CO-OCCURRING MOOD DISORDERS, SUCH AS DEPRESSION OR ANXIETY.

  • Depression
  • Mental Health
  • United States
  • World
  • Forecast
  • BIPOLAR DISORDER (MANIC DEPRESSION)
  • Depression - Product Development Milestones

NEUROKININ ## RECEPTOR (NK##R) PLAYS A VITAL ROLE IN INDUCING DEPRESSION OF GAMMA-AMINOBUTYRIC ACID-A (GABAA) RECEPTORS IN NEURONS.

  • Depression
  • Therapy
  • Company
  • Product Initiative
  • Anavex Life Sciences Corp.
  • TOP COMPANIES PARTICIPATING IN BIPOLAR DISORDER (MANIC DEPRESSION) THERAPEUTICS CLINICAL TRIALS
  • Latest Clinical Trials News on Bipolar Disorder (Manic Depression)

BIPOLAR DISORDER (MANIC DEPRESSION) THERAPEUTICS, G## COUNTRIES, CLINICAL TRIALS BY PHASE, 2017* Clinical Trials by Phase in G## Countries BIPOLAR DISORDER (MANIC DEPRESSION) THERAPEUTICS, G## COUNTRIES, CLINICAL TRIALS BY PHASE, 2017* BIPOLAR DISORDER (MANIC DEPRESSION) THER

  • Bipolar Disorder
  • Clinical Trial
  • Depression
  • Neurology
  • World
  • 07. Disorder Overview
  • 06. Introduction

According to the CDC, about one in every ## individuals in the US suffers from depression.

  • Depression
  • Actavis plc
  • Bristol-Myers Squibb Company
  • Eli Lilly & Co.
  • GlaxoSmithKline plc
  • 3.1 BIBLIOGRAPHY
  • PREVALENCE OF THE MOST FREQUENT PSYCHIATRIC COMORBIDITIES IN INDIVIDUALS WITH AND WITHOUT

According to the World Health Organization (WHO), depression is one of the major contributors to the global burden of disease (WHO, 2015).

  • Depression
  • Japan
  • United States
  • World
  • Forecast

Major depression is one of the most common mental disorders in the United Stat.

  • Depression
  • Mental Health
  • Pathology
  • United States
  • Market Size
  • DEPRESSION)
  • DEPRESSION - PIPELINE BY CALICO LLC

TNX-## SL IS AN INVESTIGATIONAL NEW DRUG AND HAS NOT BEEN APPROVED FOR ANY INDICATION. ##. ##. ##. ## ## Mar ## ##, ## ##: Tonix Pharmaceuticals to Present at the B.

  • Depression
  • Therapy
  • Company
  • Product Initiative
  • Otsuka Pharmaceutical Co., Ltd.
  • Bipolar Disorder (Manic Depression)
  • Bipolar Disorder (Manic Depression)

" Bipolar depression is a serious and impairing condition of bipolar I disorder.

  • Depression
  • Therapy
  • Company
  • Product Initiative
  • Anavex Life Sciences Corp.